Concepedia

Author

Tadafumi Terada

Taiho Pharmaceutical (Japan)

Also Known As

TADAFUMI TERADA, Tadafumi TERADA, Tadafumi Terada

24

Publications

394

Citations

12

H-Index

30

Concepts

All Affiliations

Taiho Pharmaceutical (Japan)Collaborative Research GroupGifu Pharmaceutical UniversityKurume UniversityKyushu University
TT

About

Tadafumi Terada is an author at Taiho Pharmaceutical (Japan) specializing in medicine, pharmacology, and medicinal chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

174

2

Natural Sciences

3

3

45

3

Biochemistry

3

3

45

4

Engineering

1

1

42

5

Biomolecular Engineering

1

1

42

Tadafumi Terada

×

12

Publications

333

Citations

12

H-Index

YearCitations

Antitumor agents. 3. Synthesis and biological activity of 4.beta.-alkyl derivatives containing hydroxy, amino, and amido groups of 4'-O-demethyl-4-desoxypodophyllotoxin as antitumor agents

Tadafumi Terada, Katsuhiko Fujimoto, Makoto Nomura,

Journal of Medicinal Chemistry

1993

64

Synthesis of 24,24-difluoro- and 24ξ-fluoro-25-hydroxyvitamin D3

Yoshiro Kobayashi, Takeo Taguchi, Tadafumi Terada,

Tetrahedron Letters

1979

42

TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.

Yasuji Yamamoto, Jiro Shibata, Kazuhiko Yonekura,

PubMed

2005

34

Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structural Relationship of Podophyllotoxin Derivatives as Antitumor Agents.

Tadafumi Terada, Katsuhiko Fujimoto, Makoto Nomura,

Chemical and Pharmaceutical Bulletin

1992

32

Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity

Kenji Suzuki, Hideko Nagasawa, Yoshihiro Uto,

Bioorganic & Medicinal Chemistry

2005

32

TAS-108, a Novel Oral Steroidal Antiestrogenic Agent, Is a Pure Antagonist on Estrogen Receptor α and a Partial Agonist on Estrogen Receptor β with Low Uterotrophic Effect

Yasuji Yamamoto, Jiro Shibata, Kazuhiko Yonekura,

Clinical Cancer Research

2005

31

A novel cinnamic acid derivative that inhibits Cdc25 dual‐specificity phosphatase activity

Yoshimi Aoyagi, Norio Masuko, Shuichi Ohkubo,

Cancer Science

2005

23

Studies on organic fluorine compounds. Part 37. Studies on steroids. Part 78. Synthesis of 24,24-difluoro- and 24ξ-fluoro-25-hydroxyvitamin D<sub>3</sub>

Yoshiro Kobayashi, Takeo Taguchi, Tadafumi Terada,

Journal of the Chemical Society Perkin Transactions 1

1982

21

The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-α

Shinji Oie, Mayumi Ono, Hirohisa Yano,

International Journal of Oncology

2006

16

Alteration of dihydropyrimidine dehydrogenase expression by IFN-α affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells

Shinji Oie, Mayumi Ono, Hiroto Fukushima,

Molecular Cancer Therapeutics

2007

14

Page 1